Back to News
Market Impact: 0.45

Israel stocks lower at close of trade; TA 35 down 2.33%

UBSORAESLTNICEPHOECLIS
Market Technicals & FlowsCompany FundamentalsCommodities & Raw MaterialsEnergy Markets & PricesCurrency & FXAnalyst InsightsArtificial IntelligenceFutures & Options
Israel stocks lower at close of trade; TA 35 down 2.33%

The Israeli TA 35 index declined 2.33% on Sunday, primarily due to significant losses in the Insurance, Financials, and Real Estate sectors, with NICE Ltd falling 7.85% and Clal Insurance Enterprises Holdings Ltd down 4.38%. Conversely, Ormat Technologies rose 1.59%. Concurrently, crude oil and Brent oil futures advanced over 2.5%, and gold futures increased 1.15%, while the USD and EUR strengthened against the ILS.

Analysis

The Israeli equity market experienced a significant downturn, with the TA 35 index falling 2.33% in a single session. The decline was broad-based, as evidenced by falling stocks outnumbering advancers by more than a three-to-one margin (360 to 102), and was primarily driven by substantial losses in the Insurance, Financials, and Real Estate sectors. Specific large-cap decliners underscore the negative sentiment, with NICE Ltd dropping 7.85%, Phoenix Holdings down 4.95%, and Clal Insurance falling 4.38%. In contrast, pockets of resilience were observed in stocks like Ormat Technologies, which gained 1.59%. This equity market weakness coincided with a notable weakening of the Israeli Shekel, which lost 0.76% against the US Dollar and 0.67% against the Euro. Concurrently, global commodity markets showed strength, with both WTI and Brent crude oil futures rising over 2.5% and gold futures advancing 1.15%, suggesting a potential flight to hard assets amid regional equity volatility. A paradoxical element is the coverage of Clal Insurance (CLIS); despite its sharp price drop, the article presents it as a potential undervalued opportunity highlighted by an AI tool, juxtaposing its poor daily performance with a speculative value thesis.

AllMind AI Terminal

AI-powered research, real-time alerts, and portfolio analytics for institutional investors.

Request a Demo